Helplessness/hopelessness, minimization and optimism predict survival in women with invasive ovarian cancer: a role for targeted support during initial treatment decision-making?

Supportive Care in Cancer

Volumn 24, Issue 6, 2016, Pages 2627-2634

  Price, Melanie A ^a   Butow, Phyllis N ^a   Bell, Melanie L ^a,b   deFazio, Anna ^c   Friedlander, Michael ^d,e   Fardell, Joanna E ^a   Protani, Melinda M ^f   Webb, Penelope M ^f   AOCS Quality of Life Study Investigators on behalf of the Australian Ovarian Cancer Study Group ^a,c,f  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF ARIZONA   (United States)

^c WESTMEAD HOSPITAL   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e PRINCE OF WALES HOSPITAL   (Australia)

^f QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Oncology; Ovarian cancer; Predictors; Psychological factors; Survival

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER GROWTH; CANCER SURVIVAL; CANCER THERAPY; CLINICAL DECISION MAKING; DEPRESSION; FEMALE; FOLLOW UP; HELPLESSNESS; HOPELESSNESS; HUMAN; MAJOR CLINICAL STUDY; OPTIMISM; OVARY CANCER; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; QUALITY OF LIFE; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; TUMOR INVASION; DECISION MAKING; EPIDEMIOLOGY; HOPE; LEARNED HELPLESSNESS; MIDDLE AGED; MORTALITY; OVARY TUMOR; PSYCHOLOGY;

ADULT; AGED; AUSTRALIA; DECISION MAKING; DEPRESSION; FEMALE; HELPLESSNESS, LEARNED; HOPE; HUMANS; MIDDLE AGED; OPTIMISM; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS; QUALITY OF LIFE; SOCIAL SUPPORT;

EID: 84953339807     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-015-3070-5     Document Type: Article

References (40)

1. Australian Institute of Health and Welfare & National Breast and Ovarian Cancer Centre. Ovarian Cancer in Australia: an overview, 2010. Canberra.
2. Coleman MP, Forman D, Bryant H, et al. (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377(9760):127–138. doi:10.1016/S0140-6736(10)62231-3
3. Parker PA, Baile WF, deMoor C, Cohen L (2003) Psychosocial and demographic predictors of quality of life in a large sample of cancer patients. Psycho-Oncology 12(2):183–193
4. Punnen S, Cowan JE, Dunn LB, Shumay DM, Carroll PR, Cooperberg MR (2013) A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer. BJU International. 112(2):E67–E75. doi:10.1111/bju.12209
5. Antoni MH, Lechner S, Diaz A, et al. (2009) Cognitive behavioral stress management effects on psychosocial and physiological adaptation in women undergoing treatment for breast cancer. Brain Behav Immun 23(5):580–591. doi:10.1016/j.bbi. 2008.09.005
6. Irwin ML, Mayne ST (2008) Impact of nutrition and exercise on cancer survival. Cancer J 14(6):435–441. doi:10.1097/PPO.0b013e31818daeee
7. Watson M, Homewood J, Haviland J (2012) Coping response and survival in breast cancer patients: a new analysis. Stress Health 28(5):376–380. doi:10.1002/smi.2459
8. Carver CS, Scheier MF, Segerstrom SC (2010) Optimism. Clin Psychol Rev 30(7):879–889
9. Antoni MH, Lutgendorf SK, Cole SW, et al. (2006) The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer 6(3):240–248. doi:10.1038/nrc1820
10. Antoni MH. Psychosocial intervention effects on adaptation, disease course and biobehavioral processes in cancer. Brain Behav Immun. 2013; 30(SI):S88-S98. doi:10.1016/j.bbi. 2012.05.009
11. Butow P, Coates AS, Dunn SM (1999) Psychosocial predictors of survival in metastatic melanoma. J Clin Oncol 17(7):2256–2263. doi:10.1054/bjoc. 2000.1471
12. Brown JE, Butow PN, Culjak G, Coates AS, Dunn SM (2000) Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanoma. Br J Cancer 83(11):1448–1453. doi:10.1054/bjoc. 2000.1471
13. Butow P, Coates AS, Dunn SM (2000) Psychosocial predictors of survival: metastatic breast cancer. Ann Oncol 11(4):469–474. doi:10.1038/sj.bjc.6603091
14. Butow PN, Brown JE, Coates AS, Dunn SM (2001) Psychosocial predictors of outcome IV: patients with early-stage breast cancer. Breast 10(Suppl 3):182–189
15. Petticrew M, Bell R, Hunter D (2002) Influence of psychological coping on survival and recurrence in people with cancer: systematic review. BMJ 325(7372):1066. doi:10.1136/bmj.325.7372.1066
16. Kroenke CH, Kubzansky LD, Schernhammer ES, Holmes MD, Kawachi I (2006) Social networks, social support, and survival after breast cancer diagnosis. J Clin Oncol 24(7):1105–1111. doi:10.1200/JCO. 2005.04.2846
17. Chida Y, Hamer M, Wardle J, Steptoe A (2008) Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Rev Clin Oncol 5:466–475. doi:10.1038/ncponc1134
18. Satin JR, Linden W, Phillips MJ (2009) Depression as a predictor of disease progression and mortality in cancer patients. Cancer 115(22):5349–5361. doi:10.1002/cncr.24561
19. Dahl AA (2010) Link between personality and cancer. Future Oncol 6(5):691–707. doi:10.2217/fon.10.31
20. Martin Pinquarta M, Dubersteinb PR (2010) Associations of social networks with cancer mortality: a meta-analysis. Crit Rev Oncol Hematol 75(2):122–137. doi:10.1016/j.critrevonc. 2009.06.003
21. Lutgendorf SK, De Geest K, Bender D, et al. (2012) Social influences on clinical outcomes of patients with ovarian cancer. J Clin Oncol 30(23):2885–2890. doi:10.1200/JCO. 2011.39.4411
22. Spiegel D, Butler LD, Giese-Davis J, et al. (2007) Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: a randomized prospective trial. Cancer 110(5):1130–1138. doi:10.1002/cncr.22890
23. Kissane D, Li Y (2008) Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: a randomized prospective trial. Cancer 112(2):443–444. doi:10.1002/cncr.23179
24. Kissane D (2009) Beyond the psychotherapy and survival debate: the challenge of social disparity, depression and treatment adherence in psychosocial cancer care. Psycho-Oncology 18(1):1–5. doi:10.1002/pon.1493
25. Spiegel D (2012) Mind matters in cancer survival. Psycho-Oncology 21(6):588–593. doi:10.1002/pon.3067
26. Lutgendorf SK, Sood AK, Anderson B, et al. (2005) Social support, psychological distress, and natural killer cell activity in ovarian cancer. J Clin Oncol 23(28):7105–7113. doi:10.1200/JCO. 2011.39.4411
27. Costanzo ES, Lutgendorf SK, Sood AK, Anderson B, Sorosky J, Lubaroff DM (2005) Psychosocial factors and interleukin-6 among women with advanced ovarian cancer. Cancer 104(2):305–313. doi:10.1002/cncr.21147
28. Jordan SJ, Green AC, Whiteman DC, et al. (2008) Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis. Int J Cancer 122:1598–1603. doi:10.1002/ijc.23287
29. Price MA, Zachariae R, Butow PN, et al. (2009) Prevalence and predictors of insomnia in women with invasive ovarian cancer: anxiety a major factor. Eur J Cancer 45(18):3262–3270. doi:10.1016/j.ejca. 2009.05.030
30. Price MA, Butow PN, Costa DS, et al. (2010) Prevalence and predictors of anxiety and depression in women with invasive ovarian cancer and their carers. Med J Aust 193(5 Suppl):S52–S57
31. Rustin GJS, Vergote I, Eisenhauer E, et al. (2011) Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG). Int J Gynecol Cancer 21(2):419–423. doi:10.1097/IGC.0b013e3182070f17
32. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica. 67(6):361–370. doi:10.1111/j.1600-0447.1983.tb09716.x
33. Osborne RH, Elsworth GR, Kissane DW, Burke SA, Hopper JL (1999) The Mental Adjustment to Cancer (MAC) scale: replication and refinement in 632 breast cancer patients. Psychol Med 29(6):1335–1145. doi:10.1200/JCO. 2014.57.6801
34. Watson M, Greer S, Young J, Inayat Q, Burgess C, Robertson B (1988) Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med 18(1):203–209. doi:10.1017/S0033291700002026
35. Scheier MF, Carver CS, Bridges MW (1994) Distinguishing optimism from neuroticism (and trait anxiety, self mastery, and self esteem): a reevaluation of the life orientation test. J Pers Soc Psychol 67(6):1063–78. doi:10.1037/0022-3514.67.6.1063
36. Broadhead WE, Gehbach SH, de Gruy FV, Kaplan BH (1988) The Duke-UNC Functional Social Support Questionnaire. Measurement of social support in family medicine patients. Med Care 26(7):709–723
37. Garssen B (2004) Psychological factors and cancer development: evidence after 30 years of research. Clin Psychol Rev 24(3):315–338. doi:10.1016/j.cpr. 2004.01.002
38. Danhauer SC, Crawford SL, Farmer DF, Avis NE (2009) A longitudinal investigation of coping strategies and quality of life among younger women with breast cancer. J Behav Med 32(4):371–379. doi:10.1007/s10865-009-9211-x
39. Goncalves V, Jayson G, Tarrier N (2008) A longitudinal investigation of psychological morbidity in patients with ovarian cancer. Br J Cancer 99(11):1794–1801. doi:10.1038/sj.bjc.6604770
40. Australian Cancer Network and National Breast Cancer Centre. Clinical practice guidelines for the management of women with epithelial ovarian cancer. Camperdown, Sydney, Australia: National Breast Cancer Centre; 2004.